Clinical Trials List
2023-12-15 - 2028-06-30
Phase III
Recruiting6
ICD-10E85.0
Non-neuropathic heredofamilial amyloidosis
ICD-10E85.1
Neuropathic heredofamilial amyloidosis
ICD-10E85.2
Heredofamilial amyloidosis, unspecified
ICD-10E85.3
Secondary systemic amyloidosis
ICD-10E85.4
Organ-limited amyloidosis
ICD-10E85.8
Other amyloidosis
ICD-10E85.9
Amyloidosis, unspecified
ICD-9277.3
Amyloidosis
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 郭泠 Division of Cardiovascular Diseases
- Yo-Tsen Liu Division of Neurology
- 王維庭 Division of Cardiovascular Diseases
- Kon-Ping Lin Division of Neurology
- Yi-Chu Liao Division of Neurology
- Yi-Chun Lee Division of Neurology
- 廖若男 Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- 季康揚 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- WEI-WEN LIN Division of Cardiovascular Diseases
- 周政達 Division of Neurology
- 王奇彥 Division of Cardiovascular Diseases
- 黃祺耀 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林恆旭 無
- YEN-HSIANG HUANG 無
- 曾炳憲 無
- 許榮城 無
- 莊文博 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Jen Lee 無
- Chi-Chao Chao 無
- JEN-KUANG LEE 無
- 陳俊凱 無
- SUNG-TSANG HSIEH 無
- CHO-KAI WU 無
- JYH-MING JIMMY JUANG 無
- HSUEH-WEN HSUEH 無
- 江君揚 無
- 蔡承烜 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂尚謁 無
- 董承昌 無
- Yuh-Cherng Guo 無
- 林晏年 無
- 鍾偉信 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kon-Ping Lin Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
1000 participants
